SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Zenity raises $125 million Series C as AI agent security startup accelerates global expansion

Former shipping chief backs new Zim, challenging warnings over $4.2 billion deal

BlackRock expands Nova holding with $262 million share purchase as AI drives chip demand

Deel surpasses $1.5 billion ARR as global workforce platform targets next phase

Buzz

Most popular

Daily

Weekly

1

Israel searches for technology that could find soldiers and pilots who cannot call for help

2

Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount

3

Two Israeli startups raised half a billion dollars. Their exits reveal the cost of the funding boom

4

Former Palantir and Torq veterans raise $8 million Seed to secure the rise of AI agents

5

Israeli startups raised $1.5 billion in July as investors doubled down on enterprise AI

Polypid

6 stories about Polypid

מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer

Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body

CTech’s Sunday Roundup of Israeli Tech News

U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO

חיים הורביץ איש עסקים דירקטור ב חברת טבע

Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO

25.03.18|Dror Reich

The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week

אלביט מערכות נתנאל גרופ פארק תמר רחובות

CTech’s Thursday Israeli Tech News Roundup

Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees

נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO

15.03.18|Dror Reich

The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery

Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO

11.02.18|Dror Reich

The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities